• 05.02.2019, 14:18:38
  • /
  • OTE0005

EANS-DD: Marinomed Biotech AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to article 19 Market Abuse Regulation (MAR) - ATTACHMENT

--------------------------------------------------------------------------------
Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by
euro adhoc with the aim of a Europe-wide distribution. The issuer is
responsible for the content of this announcement.
--------------------------------------------------------------------------------

personal data:

responsible party:

name: Ute Lassnig (natural person)

--------------------------------------------------------------------------------

reason:

reason: responsible party is a person with managerial responsibilities
function: Member of an administrative or supervisory board

--------------------------------------------------------------------------------

issuer information:

name: Marinomed Biotech AG
Legal Entity Identifier (LEI): 529900GN3B1EN80XF405

--------------------------------------------------------------------------------

information about deal:

ISIN: ATMARINOMED6
description of the financial instrument: Stock
type: acquisition
date: 30.01.2019; UTC+01:00
market: WIENER BOERSE AG, XWBO
currency: Euro

price volume
75 570

total volume: 570
total price: 42750
average price: 75

--------------------------------------------------------------------------------

end of announcement euro adhoc
--------------------------------------------------------------------------------

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/documents/10197870/4/10261271/1/DD_Lassnig_Laureo_2019_01_31.pdf

issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: office@marinomed.com
WWW: www.marinomed.com
ISIN: AT0000A1WD52, ATMARINOMED6
indexes:
stockmarkets: Wien
language: English

ORIGINAL APA-OTS TEXT - THE INFORMATION CONTAINED IN THIS PRESS RELEASE IS SUBJECT TO THE EXCLUSIVE RESPONSIBILITY OF THE ISSUER | EAE

Bei Facebook teilen.
Bei X teilen.
Bei LinkedIn teilen.
Bei Xing teilen.
Bei Bluesky teilen

Stichworte

Channel